Company: XERI
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001477932-25-001010
Chunk: 4

Company: XERIANT, INC.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
 30, 2024  699,416   7   1,000,000   10   570,184,486   5,702   51,950   21,385,746   (27,073,761)  (2,867,317)  (8,497,663)                                             Stock issued for services  -   -   -   -   967,000   10   -   14,495   -   -   14,505                                              Conversion of Series A Preferred to Common Stock  (17,200)  -   -   -   17,200,000   172   -   (172)  -   -   -                                              Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   16,500,000   165   45,950   164,835   -   -   210,950                                              Cashless exercise of warrants  -   -   -   -   1,528,185   15   -   (15)  -   -   -                                              Net loss  -   -   -   -   -   -   -   -   (410,050)  (7,219)  (417,269)                                             Balance December 31, 2024  682,216  $7   1,000,000  $10   606,379,671  $6,064  $97,900  $21,564,889  $(27,483,811) $(2,874,536) $(8,689,477)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 F-4Table of Contents

XERIANT, INC. CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICITFOR THE THREE AND SIX MONTHS ENDED DECEMBER 31, 2023UN